TrialJectoryTrialJectory
TrialJectory

TrialJectory

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Website
2017Active17
Advertise here

About

TrialJectory is an AI-powered decision support platform that democratizes access to advanced cancer treatments. It empowers patients to own their cancer journey by providing instant, personalized lists of cutting-edge treatments matched to their exact diagnosis, free of pharmaceutical bias. The company serves cancer patients by connecting them with treatment options and offers dedicated support from a team of medical professionals.

Technology stack

detected 2026-06-09
Est. monthly stack spend~$210/mo
CDN
AWS CloudFront
EmailGoogle Workspace
Hosting
AWS
Stack
Next.js
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does TrialJectory do?

TrialJectory is an AI-powered decision support platform that democratizes access to advanced cancer treatments. It empowers patients to own their cancer journey by providing instant, personalized lists of cutting-edge treatments matched to their exact diagnosis, free of pharmaceutical bias. The company serves cancer patients by connecting them with treatment options and offers dedicated support from a team of medical professionals.

How much funding has TrialJectory raised?

TrialJectory has raised a total of $40M in funding. The most recent round on record is Series A.

Where is TrialJectory headquartered?

TrialJectory is headquartered in New York, United States.

When was TrialJectory founded?

TrialJectory was founded in 2017.

What industry does TrialJectory operate in?

TrialJectory operates in Healthcare, Clinical Trials, Cancer, HealthTech, MedTech, Drug Discovery.

How many employees does TrialJectory have?

TrialJectory has approximately 17 people on record.